Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Nu Holdings
NU
5
Liberty Latin America-A
LILA
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 54.58%593.9M | 159.60%246.1M | 163.52%164.7M | -33.33%107.8M | 15.49%75.3M | 4.20%384.2M | -5.39%94.8M | 38.89%62.5M | 102.89%161.7M | -54.66%65.2M |
Net income from continuing operations | 131.05%192M | 643.39%102.7M | 1,201.82%60.6M | -50.44%34M | -113.62%-5.3M | -37.33%83.1M | -146.10%-18.9M | 14.06%-5.5M | 253.61%68.6M | -50.51%38.9M |
Operating gains losses | -440.00%-10.2M | 128.36%1.9M | -135.14%-1.3M | -538.46%-17.1M | 200.00%6.3M | -78.87%3M | 59.15%-6.7M | -76.13%3.7M | -77.06%3.9M | 210.53%2.1M |
Depreciation and amortization | 40.38%321.2M | 39.97%100.5M | 66.34%86M | 16.11%69.9M | 43.68%64.8M | 13.72%228.8M | 36.76%71.8M | 11.66%51.7M | 27.81%60.2M | -18.44%45.1M |
Asset impairment expenditure | -78.33%8.3M | -95.04%1.9M | --1.7M | --4.7M | ---- | 770.45%38.3M | --38.3M | --0 | --0 | ---- |
Remuneration paid in stock | -69.77%1.3M | -20.93%3.4M | ---2.1M | ---- | ---- | --4.3M | --4.3M | --0 | ---- | ---- |
Remuneration paid in stock | 95.07%27.7M | 335.71%12.2M | 208.70%7.1M | -2.78%3.5M | -10.91%4.9M | 97.22%14.2M | 64.71%2.8M | 64.29%2.3M | 38.46%3.6M | 266.67%5.5M |
Deferred tax | 56.94%55.4M | 1,592.59%40.3M | -29.07%6.1M | -89.42%2M | -33.33%7M | 3.82%35.3M | -124.55%-2.7M | 714.29%8.6M | 200.00%18.9M | -41.99%10.5M |
Other non cashItems | 159.09%2.6M | 27.03%-2.7M | 422.22%2.9M | 1,050.00%2.3M | --100K | 12.00%-4.4M | -208.33%-3.7M | 25.00%-900K | 107.14%200K | ---- |
Change In working capital | 76.09%-4.4M | -246.88%-14.1M | 42.31%3.7M | 34.92%8.5M | 93.22%-2.5M | 7.54%-18.4M | -17.24%9.6M | 128.26%2.6M | 156.76%6.3M | -229.46%-36.9M |
-Change in receivables | 223.19%32.4M | 111.17%2M | 105.66%300K | 348.65%33.2M | 70.48%-3.1M | -32.16%-26.3M | -92.47%-17.9M | -201.92%-5.3M | 840.00%7.4M | 29.05%-10.5M |
-Change in inventory | 159.51%9.7M | -1,353.85%-18.9M | 111.97%1.4M | 925.00%8.2M | 563.41%19M | -2.52%-16.3M | 75.00%-1.3M | -4,000.00%-11.7M | 107.55%800K | -925.00%-4.1M |
-Change in payables and accrued expense | -103.54%-900K | -59.15%9.6M | -37.50%11M | -115.91%-9.5M | -6.19%-12M | -7.97%25.4M | -2.49%23.5M | 509.30%17.6M | -186.27%-4.4M | -518.52%-11.3M |
-Change in other working capital | -3,700.00%-45.6M | -228.30%-6.8M | -550.00%-9M | -1,036.00%-23.4M | 41.82%-6.4M | 89.74%-1.2M | 165.00%5.3M | 119.23%2M | 154.35%2.5M | -946.15%-11M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 54.58%593.9M | 159.60%246.1M | 163.52%164.7M | -33.33%107.8M | 15.49%75.3M | 4.20%384.2M | -5.39%94.8M | 38.89%62.5M | 102.89%161.7M | -54.66%65.2M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -2.02%-348.7M | -26.56%-99.6M | -7.49%-99M | 14.32%-76.6M | 9.93%-73.5M | -21.72%-341.8M | 12.75%-78.7M | -67.15%-92.1M | -40.57%-89.4M | -13.49%-81.6M |
Net PPE purchase and sale | -8.66%-380.2M | -23.83%-100.8M | -7.14%-99M | -13.12%-106.9M | 9.93%-73.5M | -24.61%-349.9M | 9.76%-81.4M | -67.70%-92.4M | -48.58%-94.5M | -13.49%-81.6M |
Net other investing changes | 288.89%31.5M | -55.56%1.2M | ---- | 494.12%30.3M | ---- | --8.1M | --2.7M | --300K | --5.1M | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -2.02%-348.7M | -26.56%-99.6M | -7.49%-99M | 14.32%-76.6M | 9.93%-73.5M | -21.72%-341.8M | 12.75%-78.7M | -67.15%-92.1M | -40.57%-89.4M | -13.49%-81.6M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -108.48%-120.5M | -768.35%-120.7M | -193.83%-66.7M | 426.71%47.7M | 390.91%19.2M | 55.61%-57.8M | 75.74%-13.9M | -228.99%-22.7M | 74.52%-14.6M | 24.14%-6.6M |
Net issuance payments of debt | -286.44%-168.1M | -1,238.24%-91M | -122.47%-50.5M | -518.92%-45.8M | 390.91%19.2M | 66.59%-43.5M | 88.13%-6.8M | -228.99%-22.7M | 87.09%-7.4M | 24.14%-6.6M |
Net common stock issuance | --81.9M | ---16.3M | ---7.8M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Cash dividends paid | 1.40%-14.1M | 0.00%-7.1M | --0 | 2.78%-7M | ---- | ---14.3M | ---7.1M | --0 | ---7.2M | ---- |
Net other financing activities | ---20.2M | ---6.3M | ---8.4M | --100.5M | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -108.48%-120.5M | -768.35%-120.7M | -193.83%-66.7M | 426.71%47.7M | 390.91%19.2M | 55.61%-57.8M | 75.74%-13.9M | -228.99%-22.7M | 74.52%-14.6M | 24.14%-6.6M |
Net cash flow | ||||||||||
Beginning cash position | -25.84%61.7M | 163.02%158.6M | 37.26%157.3M | 39.83%81.1M | -25.84%61.7M | -37.44%83.2M | -53.69%60.3M | -23.70%114.6M | -70.21%58M | -37.44%83.2M |
Current changes in cash | 909.74%124.7M | 1,072.73%25.8M | 98.09%-1M | 36.74%78.9M | 191.30%21M | 63.59%-15.4M | 104.65%2.2M | -207.65%-52.3M | 240.05%57.7M | -136.39%-23M |
Effect of exchange rate changes | 216.39%7.1M | 1,237.50%9.1M | 215.00%2.3M | -145.45%-2.7M | 27.27%-1.6M | 18.67%-6.1M | -366.67%-800K | 33.33%-2M | 66.67%-1.1M | -46.67%-2.2M |
End cash Position | 213.61%193.5M | 213.61%193.5M | 163.02%158.6M | 37.26%157.3M | 39.83%81.1M | -25.84%61.7M | -25.84%61.7M | -53.69%60.3M | -23.70%114.6M | -70.21%58M |
Free cash from | 523.03%213.7M | 984.33%145.3M | 319.73%65.7M | -98.66%900K | 110.98%1.8M | -60.57%34.3M | 36.73%13.4M | -184.76%-29.9M | 320.00%67.2M | -122.87%-16.4M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.